Canada approves Pfizer’s COVID-19 vaccine for children aged 5-11 years


The Government of Canada has approved Pfizer’s COVID-19 vaccine for children aged 5 to 11 years of age.

“After a thorough and independent scientific review of the evidence, the Department has determined that the benefits of this vaccine for children between 5 and 11 years of age outweigh the risks. Health Canada has authorized a two-dose regimen of 10 micrograms to be administered three weeks apart, which is a lower dose than the 30 micrograms two-dose regimen authorized for people 12 years of age and older,” the Health Canada said in a statement.

The statement further added that the clinical trial showed that the immune response in children 5 to 11 years of age was comparable to the immune response in people 16 to 25 years of age. The vaccine was 90.7% effective at preventing COVID-19 in children 5 to 11 years of age and no serious side effects were identified.

Canada expects to receive 2.9 million doses of the vaccine next week, Prime Minister Justin Trudeau said in a statement posted online.

“That means, in a matter of days, we’ll have enough doses for every eligible child to get their first shot,” Prime Minister Trudeau tweeted.

Health Canada received a submission from Pfizer-BioNTech last month, seeking an authorization for the use of its Comirnaty COVID-19 vaccine in children 5 to 11 years of age.



Please enter your comment!
Please enter your name here